Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest Radiofrequency ablation Stories

2012-07-24 13:05:54

University of Michigan heart researchers are shedding light on a safer method for steadying an abnormal heart rhythm that prevents collateral damage to healthy cells. Irregular heart rhythms, or arrhythmias, set the stage for a common, debilitating disorder called atrial fibrillation that puts adults as young as age 40 at risk for fatigue, fainting, cardiac arrest, and even death. Medications can help, but doctors also use catheter ablation in which electrical impulses are delivered to a...

2012-07-24 10:12:22

American Heart Association meeting report: BCVS-12 Abstract 25 The first study of a procedure to make three-dimensional "maps" of electrical signals in children's hearts could help cardiologists correct rapid heart rhythms in young patients, according to new research presented at the American Heart Association's Basic Cardiovascular Sciences 2012 Scientific Sessions. Children with the condition atrioventricular nodal reentrant tachycardia, or AVNRT, suffer from disruptions in the...

2012-06-04 06:26:50

CAESAREA, Israel and CLEVELAND, June 4, 2012 /PRNewswire/ -- IceCure Medical Ltd. announced the first four breast cancer patients treated with the IceSense3(TM) Cryoablation Procedure in Japan. The IceSense3 System was used to treat small breast cancer tumors in a minimally invasive procedure using ultrasound guidance and local anesthesia. These patients were the first four enrolled in a clinical trial of 30 small, early stage breast cancer patients at Kameda Medical Center in Kamogawa City,...

2012-05-10 02:31:51

MORRISVILLE, N.C., May 10, 2012 /PRNewswire/ -- Electrophysiology thought leaders gathered to discuss the significance of posterior ablation in the treatment of arrhythmias, with presentations highlighting the importance of isolating the posterior left atrium with an adjunctive epicardial treatment. The symposium was supported by nContact, Inc. and held in conjunction with Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions, in Boston, MA, on the evening of May 8....

2012-05-02 02:27:55

MORRISVILLE, N.C., May 2, 2012 /PRNewswire/ -- nContact, Inc., the leading innovator in epicardial ablation devices, today announced its technology will be included in an oral presentation during an abstract session and two poster presentations at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions, May 9-12 in Boston, MA. nContact's Numeris® Coagulation System with VisiTrax® and EPi-Sense(TM) Coagulation System technology integrates suction, perfusion, and...

2012-04-11 02:24:45

NATICK, Mass., April 11, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces the U.S. market launch of its Z Flex-270(TM) Steerable Sheath. The device is intended for use in a wide range of electrophysiology (EP) procedures to facilitate the introduction and placement of diagnostic and therapeutic catheters within the heart. The Company plans to launch the product immediately in the U.S. "The Z Flex-270 Steerable Sheath provides more than 270 degrees of tip deflection...

2012-03-27 02:27:20

MORRISVILLE, N.C., March 27, 2012 /PRNewswire/ -- nContact, Inc., the leading innovator in epicardial ablation devices, today announced that CEO John Funkhouser spoke at the American College of Cardiology's (ACC) Cardiovascular Innovations Educational Forum in Chicago, IL, on the future of cardiac ablation under managed care. The theme of the talk was anticipated managed care requirements for the industry, and though the exact form they will take is uncertain, the presentation contained...

2012-02-24 17:30:00

PALM SPRINGS, Calif., Feb. 24, 2012 /PRNewswire-USNewswire/ -- Today at the American Academy of Pain Medicine's 28th Annual Meeting, researchers from Cleveland Clinic report that there is no evidence that the degree of pain relief from intraarticular steroid injections of the sacroiliac joint predicts the outcome of radiofrequency ablation (RFA) of the lateral branches in patients suffering with low back pain. The study was presented by Jianguo Cheng, M.D., Ph.D., Professor of Anesthesiology...

2012-02-23 07:01:00

MORRISVILLE, N.C., Feb. 23, 2012 /PRNewswire/ -- nContact, Inc., the leading innovator in epicardial ablation devices, today announced that a new preclinical study examines a unique minimally invasive percutaneous approach to accessing the heart that may enable electrophysiologists (EPs) to perform epicardial ablation for ventricular tachycardia (VT). The study was published in the February 2012 issue of The Journal of Innovations in Cardiac Rhythm Management. In the study, "Creating...

2012-02-10 12:00:00

Heart specialists at Allegheny General Hospital (AGH) have joined a select group in the country offering patients who suffer from the common and potentially deadly heart rhythm disorder ventricular tachycardia (VT) a new, minimally invasive therapy called epicardial VT ablation. Pittsburgh, PA (PRWEB) February 10, 2012 Heart specialists at Allegheny General Hospital (AGH) have joined a select group in the country offering patients who suffer from the common and potentially deadly heart...